<DOC>
	<DOC>NCT00373776</DOC>
	<brief_summary>This trial will study miltefosine as a treatment for mucosal leishmaniasis.</brief_summary>
	<brief_title>Miltefosine for Mucosal Leishmaniasis</brief_title>
	<detailed_description>Treat bolivian mucosal leishmaniasis with miltefosine.</detailed_description>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Miltefosine</mesh_term>
	<criteria>Mucosal leishmaniasis Abnormal liver function tests (LFT) Abnormal kidney function test Concomitant diseases</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>mucosal</keyword>
	<keyword>leishmaniasis</keyword>
	<keyword>miltefosine</keyword>
</DOC>